Episode 8. Management of Newly Diagnosed CLL
Blood Cancer Talks
00:00
The Future of CAR-T for CLL
Dr. Jain: Could it be that eventually for most of these, not just CLL, I'm talking about ALL as well and a DLBCL maybe for my Loma as well, that they are being introduced in early lines of therapy? We still have to develop good effective CAR-T for CLL first before we move it in the frontline setting. So I think for immediate frontline, maybe the next five years, we'll be short-term six to 12 months, double-ed octoply therapy or patient with CLL.
Transcript
Play full episode
